Previous 10 | Next 10 |
Buckling under the weight of opioid lawsuits, INSYS Therapeutics (NASDAQ: INSY ) has filed for Chapter 11 bankruptcy and will sell substantially all of its assets. More news on: INSYS Therapeutics, Inc., Healthcare stocks news, Stocks on the move, Read more ...
Company to Facilitate Transaction Process and Sale of Substantially All Assets Through Chapter 11 of the U.S. Bankruptcy Code Operations to Continue as Normal Including Payment of Employee Wages and Benefits and Continuing Programs for Customers; Vendors and Suppliers to Receive Full ...
Trying times for Insys Therapeutics (NASDAQ:INSY) have finally come to an end—but at a price. On Friday, the opioid manufacturer said it has agreed to pay a whopping $225 million to settle criminal investigations. And yet, the market doesn’t seem to mind: INSY stock is up mo...
Charles & Colvard (NASDAQ: CTHR ) -19% on Q4 and FY guidance and equity offering . More news on: Charles & Colvard, Ltd., Motif Bio plc, Domo, Inc., Stocks on the move, Read more ...
Insys Therapeutics (NASDAQ: INSY ) has been halted for volatility after an 81% jump . More news on: INSYS Therapeutics, Inc., Healthcare stocks news, Stocks on the move Read more ...
Today's Top Stories: ECB eyed amid central bank shift; more gains; and tech cold war. If you are interested in listening to Wall Street Breakfast to start your day, look for us in the following places: iTunes (find all Seeking Alpha Podcasts here ) Stitcher SoundCloud ...
Insys Therapeutics (NASDAQ: INSY ) will pay $225M and one of its units will plead guilty to mail fraud in a settlement with the government of criminal and civil charges. More news on: INSYS Therapeutics, Inc., Healthcare stocks news, Stocks on the move, Read more ...
Stacking Up Cannabis Stocks To The Bluechips This week, we compare many corporate fundamentals of the ‘Cannabis 50’ companies to the largest 50 of the S&P 500 companies. Investor euphoria over the past several years has been concentrated in the Monsters of Tech (Apple (AA...
This week we focus on 50 cannabis companies for which we, as portfolio managers, capture comprehensive investor-related data. We show how we capture the data and apply it to a proprietary algorithm to generate decision-support information. We will let the data speak for itself. But new reade...
It has not been a pleasant week for Insys Therapeutics ( INSY ), as it has announced poor first-quarter 2019 results , along with a news release providing a liquidity update in which it is stated that there is substantial doubt about the company's ability to continue as a going concern. In ...
News, Short Squeeze, Breakout and More Instantly...
Insys Therapeutics Inc. Company Name:
INSY Stock Symbol:
NASDAQ Market:
Insys Therapeutics Inc. Website:
GD Entertainment and Technology’s (OTC: GDET ) Anil Idnani, CEO, will discuss the company’s 2020 outlook when he is interviewed by Stock Market Podcast. He will focus on GDET’s new customizable, prepaid ‘Dream Card’ and also the marketing of its CBD produc...
GD Entertainment and Technology (OTC: GDET ) announces today (June 15, 2020) that Anil Idnani, CEO,will be interviewed by Stock Market Podcast and offer a review of the company’s marketing growth and 2020 outlook. The company is focusing on both its re-introduced customizable, ...
Reinforcing the strength of CBD sales, website 420 Intel reported that sales of CBD hit $103 million for the month of May — the state’s first $100 million-plus month — representing a 15% jump over April and a 60% YOY spike from May last year. It was the third straight mo...